1. Home
  2. TVRD vs ISSC Comparison

TVRD vs ISSC Comparison

Compare TVRD & ISSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TVRD
  • ISSC
  • Stock Information
  • Founded
  • TVRD 2017
  • ISSC 1988
  • Country
  • TVRD United States
  • ISSC United States
  • Employees
  • TVRD N/A
  • ISSC N/A
  • Industry
  • TVRD Biotechnology: Pharmaceutical Preparations
  • ISSC EDP Services
  • Sector
  • TVRD Health Care
  • ISSC Technology
  • Exchange
  • TVRD Nasdaq
  • ISSC Nasdaq
  • Market Cap
  • TVRD 246.5M
  • ISSC 273.0M
  • IPO Year
  • TVRD N/A
  • ISSC 2000
  • Fundamental
  • Price
  • TVRD $6.73
  • ISSC $11.72
  • Analyst Decision
  • TVRD Buy
  • ISSC
  • Analyst Count
  • TVRD 7
  • ISSC 0
  • Target Price
  • TVRD $51.67
  • ISSC N/A
  • AVG Volume (30 Days)
  • TVRD 467.6K
  • ISSC 264.3K
  • Earning Date
  • TVRD 11-21-2025
  • ISSC 08-14-2025
  • Dividend Yield
  • TVRD N/A
  • ISSC N/A
  • EPS Growth
  • TVRD N/A
  • ISSC 78.33
  • EPS
  • TVRD N/A
  • ISSC 0.66
  • Revenue
  • TVRD N/A
  • ISSC $77,434,581.00
  • Revenue This Year
  • TVRD N/A
  • ISSC $71.55
  • Revenue Next Year
  • TVRD N/A
  • ISSC $15.19
  • P/E Ratio
  • TVRD N/A
  • ISSC $18.20
  • Revenue Growth
  • TVRD N/A
  • ISSC 72.82
  • 52 Week Low
  • TVRD $5.65
  • ISSC $5.30
  • 52 Week High
  • TVRD $43.65
  • ISSC $20.00
  • Technical
  • Relative Strength Index (RSI)
  • TVRD 20.91
  • ISSC 45.68
  • Support Level
  • TVRD $5.65
  • ISSC $11.36
  • Resistance Level
  • TVRD $7.11
  • ISSC $12.65
  • Average True Range (ATR)
  • TVRD 2.47
  • ISSC 0.48
  • MACD
  • TVRD -4.16
  • ISSC 0.02
  • Stochastic Oscillator
  • TVRD 3.26
  • ISSC 32.87

About TVRD Tvardi Therapeutics Inc. Common Stock

Tvardi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development of novel, oral small molecule therapies targeting STAT3 to treat fibrosis-driven diseases. Its key product candidate, TTI-101, is in Phase 2 clinical development for the treatment of idiopathic pulmonary fibrosis (IPF), and hepatocellular carcinoma (HCC). Its second product candidate, TTI-109, is structurally related to, yet chemically distinct from, TTI-101 and is designed to enhance the ability to target STAT3.

About ISSC Innovative Solutions and Support Inc.

Innovative Solutions and Support Inc is a systems integrator that designs, manufactures, sells, and services air data equipment, engine display systems, standby equipment, primary flight guidance, and cockpit display systems for retrofit applications and original equipment manufacturers. The company supplies integrated Flight Management Systems, Flat Panel Display Systems, Integrated Standby Units, Positioning System receivers that enable reduced carbon footprint navigation, and an Autothrottle, which allows a pilot to automatically control the power setting of the engine and is designed to reduce pilot workload and enhance safety. It sells its products to both the OEM and the retrofit markets.

Share on Social Networks: